Partner Headlines - TEVA

  1. Teva Announces UK High Court Gives Positive Judgment In The Company's ...

    Benzinga
  2. 4 Biotechs That Might Be Bought Soon

    IBD
  3. Notable Hedge Funds Disclose Additions And Reductions To Holdings

    Benzinga
  4. Jana Partners LLC Files its 13F

    Benzinga
  5. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With ...

    Benzinga
  6. Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats

    IBD
  7. Did George Soros Sell His Stake In Israeli Based SodaStream Due ...

    Benzinga
  8. 5 Drug Companies Profiting From Generics

    Benzinga
  9. Top 5 Earnings Reports To Watch After The Close Tue.

    IBD
  10. Pfizer, Merck, Amgen Near Q2 Earnings Reports

    IBD
  11. George Soros Reveals His Largest Stake

    GuruFocus
  12. Sofinnova Ventures Closes $500M Fund

    FoxBusiness
  13. Israel's Market Appears Unfazed By Rising Conflict

    IBD
  14. George Soros Keeps Buying TEVA, EQT, YPF, EGN, CZR And Keeps ...

    GuruFocus
  15. UPDATE: Teva Announces FDA Acceptance of NDA For Inhaler

    Benzinga
  16. 4 Top Performing Health Care Stocks With More Potential Upside

    Benzinga
  17. Salix, Akorn, Regeneron Lead Drug Stock Rally

    IBD
  18. Top 4 Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  19. Diamond Hill Capital Comments on Teva Pharmaceutical Industries ...

    GuruFocus
  20. Diamond Hill Select Fund Commentary - First Quarter 2014

    GuruFocus
  21. Teva Pharmaceutical

    IBD
  22. Generic-Drug Makers Climb Ranks; Several In Buy Range

    IBD
  23. Teva Turmoil: Shares Up, Board Trimmed, CEO To Retire

    Benzinga
  24. Wells Fargo Initiates Coverage On The Pharmaceutical Space

    Benzinga
  25. Top Guru Held Asian Companies of the First Quarter

    GuruFocus
  26. Teva to buy Labrys Biologics

    IBD
  27. Chicago sues painkiller firms

    IBD
  28. Benzinga's M&A Chatter for Tuesday June 3, 2014

    Benzinga
  29. Teva Acquiring Labrys Biologics For Migraine Drug

    IBD
  30. Richard Snow's Top Five Highlight Finance and Healthcare Sectors

    GuruFocus
  31. Benzinga's M&A Chatter for Wednesday May 7, 2014

    Benzinga
  32. ETF Outlook For Tuesday May 6, 2014 (EUFN, ITA, EIS, UAE)

    Benzinga
  33. Wrong Marketing Lesson by Big Pharma

    GuruFocus
  34. Sterne Agee Sees Mixed Factors For Teva Pharmaceutical Industries ...

    Benzinga
  35. Teva EPS tops; rivals seen?

    IBD
  36. Market Wrap For May 1: Markets Mixed To Start The New Month

    Benzinga
  37. Earnings Scheduled For May 1, 2014

    Benzinga
  38. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD
  39. Actavis Reporting Q1 Earnings Amid Merger Frenzy

    IBD
  40. US Stock Futures Up Ahead Of Earnings, Consumer Confidence Data

    Benzinga
  41. Morning Market Losers

    Benzinga
  42. Benzinga's Top #PreMarket Losers

    Benzinga
  43. UPDATE: Teva, Oncogenex Offer Top-Line Survival Results of Phase ...

    Benzinga
  44. Nasdaq Could Be in for a Bounce

    FoxBusiness
  45. Actavis got a Pfizer

    IBD
  46. Teva Settles Patent Litigation with Pfizer on Celebrex; Has Received ...

    Benzinga
  47. Sterne Agee Sees Teva Pharmaceutical Outperformance Continuing

    Benzinga
  48. Teva Unveils Generic Lunesta Tablets in US

    Benzinga
  49. Teva Announces First Approval and Launch of Generic Lovaza® Capsules ...

    Benzinga
  50. Market Wrap For April 7: Bears In Complete Control As Markets ...

    Benzinga
  51. Citigroup Slaps $70 Price Target on Teva, Highest on Street

    Benzinga
  52. Market Wrap For March 31: Stocks Rally As Yellen Confirms Support ...

    Benzinga
  53. Analyst Offers Insight on Favorable FDA Ruling for Teva Pharma

    Benzinga
  54. Market Wrap For March 28: Markets Still Positive Despite Giving ...

    Benzinga
  55. Teva Offers Most Attractive Risk-Reward Profile, Citigroup Says

    Benzinga
  56. UPDATE: Goldman Sachs Upgrades Teva Pharmaceutical Industries

    Benzinga
  57. Forest Laboratories' Recovery

    GuruFocus
  58. Should You Buy Actavis?

    GuruFocus
  59. Horizon Pharma Banks On Two-For-One Arthritis Drugs

    IBD
  60. UPDATE: JP Morgan Upgrades Teva Pharmaceuticals

    Benzinga
  61. UPDATE: Morgan Stanley Upgrades Teva Pharmaceutical Industries ...

    Benzinga
  62. Benzinga's Top Upgrades

    Benzinga
  63. US Stock Futures Edge Higher Ahead Of Consumer Sentiment Report

    Benzinga
  64. Pfizer Loses Patent On Celebrex, Plans To Appeal

    IBD
  65. Pfizer Loses Bid to Hold Celebrex Exclusivity to '15

    FoxBusiness
  66. Will Horizon Pharma Spike Again On Quarterly Report?

    IBD
  67. UPDATE: Barclays Upgrades Teva Pharmaceutical Industries Limited ...

    Benzinga
  68. Teva upgraded on drug launch

    IBD
  69. Teva Upgraded On Strong Launch Of Next-Gen Copaxone

    IBD
  70. Weekly 52-Week Highs Highlight: COV, EQT, XLNX, TEVA

    GuruFocus
  71. UPDATE: CRT Capital Initiates Coverage on OncoGenex

    Benzinga
  72. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With ...

    Benzinga
  73. Insys Recovers From Stock Hit Tied To Fed Probe

    IBD
  74. Generic-Drug Makers Actavis, Mylan To Report Q4 Soon

    IBD
  75. #PreMarket Primer: Friday, February 7: Jobs Friday

    Benzinga
  76. Teva Pharmaceuticals A Giant In Generic Drugs

    IBD
  77. UPDATE: Teva Pharmaceutical Posts Upbeat Q4 Earnings

    Benzinga
  78. Earnings Scheduled For February 6, 2014

    Benzinga
  79. Market Wrap For January 29: Markets Lower on Fed Taper, Emerging ...

    Benzinga
  80. Stocks Hitting 52-Week Highs

    Benzinga
  81. Special Situations Alert: Details Behind Why I Bought PATH

    GuruFocus
  82. Teva, Active Biotech Say Remain Committed to Development of NERVENTRA

    Benzinga
  83. Benzinga's M&A Chatter for Tuesday January 21, 2014

    Benzinga
  84. NuPathe Terminates Agreement With Endo Pharma and Enters Into ...

    Benzinga
  85. US Stock Futures Up; Alcoa Earnings, Jobless Claims Data In Focus

    Benzinga
  86. Drug Mergers Queuing Up

    IBD
  87. Forest Buying Aptalis; Teva Bids For NuPathe Vs. Endo

    IBD
  88. Morning Market Movers

    Benzinga
  89. Benzinga's Top #PreMarket Gainers

    Benzinga
  90. Market Wrap For January 2: Markets Begin 2014 on Negative Note

    Benzinga
  91. Groups of Gurus Trade Ten-Year Low P/B Stocks - CLH, IMO and ...

    GuruFocus
  92. Market Wrap For December 27: Markets Quiet Before Weekend

    Benzinga
  93. Biologic Makers Thwart Generics: Winning Stocks

    YCharts
  94. Morning Market Movers

    Benzinga
  95. Benzinga's Top #PreMarket Gainers

    Benzinga
  96. Stocks To Watch For December 27, 2013

    Benzinga
  97. ANI Pharma Buys 31 Generic Drug Products from Teva for $12.5M ...

    Benzinga
  98. Teva Pharmaceuticals

    IBD
  99. Pfizer Settles Viagra Patent Litigation With Teva

    Benzinga
  100. Why Pfizer’s Expiring Viagra Patent Hurts Lilly Most

    YCharts
Trading Center